Point of Care Testing of Inflammatory Markers in Tears

Completed

Conditions studied: Dry Eye Syndrome

In brief

To evaluate the use of a point of care device to measure markers of inflammation in various eye conditions. In particular, matrix metalloproteinase-9 (MMP-9) will be measured. MMP-9 is an enzyme that plays a role in inflammation. The value obtained with the point of care device will be correlated with values obtained using gel electrophoresis to measure MMP-9 from the same sample. These data will be compared to clinical exam findings and questionnaires to help the investigators better understand the role of this marker of inflammation in eye diseases and possibly improve diagnostic abilities.

Key facts

Study ID

NCT02315079

Run by

University of Florida

People needed

63

Starts

2015-01-01

Expected to finish

2017-01-01

Last updated by the study team

2019-07-24

Who can join

Age: 18 and older, up to 90. Sex: any. Healthy volunteers: accepted.

You may qualify if…

• Patients that present to clinic for evaluation. Patients with and without evidence of eye inflammation will be eligible for this study.

You may not qualify if…

• Patients outside the age limits will not be eligible for the study

Where it is running

• University of Florida, Department of Ophthalmology — Gainesville, Florida, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.